Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,349 | 224 | 92.5% |
| Consulting Fee | $325.00 | 1 | 6.9% |
| Education | $25.40 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $986.01 | 42 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $518.38 | 9 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $332.66 | 21 | $0 (2019) |
| Allergan Inc. | $260.50 | 21 | $0 (2018) |
| QOL Medical, LLC | $255.84 | 23 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $229.78 | 13 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $225.66 | 13 | $0 (2017) |
| Aries Pharmaceuticals, Inc. | $217.23 | 2 | $0 (2018) |
| Gilead Sciences, Inc. | $162.20 | 9 | $0 (2018) |
| Shire North American Group Inc | $159.24 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $100.40 | 2 | Janssen Biotech, Inc. ($83.48) |
| 2019 | $731.45 | 25 | Janssen Scientific Affairs, LLC ($121.26) |
| 2018 | $1,725 | 92 | AbbVie, Inc. ($386.73) |
| 2017 | $2,142 | 108 | AbbVie, Inc. ($480.82) |
All Payment Transactions
227 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.92 | General |
| Category: PSYCHIATRY | ||||||
| 02/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $83.48 | General |
| Category: Immunology | ||||||
| 09/16/2019 | Covidien LP | Beacon (Device) | Food and Beverage | In-kind items and services | $92.68 | General |
| Category: Ablation | ||||||
| 09/04/2019 | Boston Scientific Corporation | RESOLUTION CLIP (Device) | Food and Beverage | In-kind items and services | $68.58 | General |
| Category: BILIARY DEVICES | ||||||
| 06/30/2019 | Romark Laboratories, LC | Alinia (Drug), Alinia, Alinia | Food and Beverage | Cash or cash equivalent | $16.24 | General |
| Category: Gastroenterology | ||||||
| 06/30/2019 | Romark Laboratories, LC | Alinia (Drug), Alinia, Alinia | Food and Beverage | Cash or cash equivalent | $9.38 | General |
| Category: Gastroenterology | ||||||
| 05/14/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/13/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/26/2019 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/23/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $20.28 | General |
| 04/16/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/09/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Endocrinology | ||||||
| 04/08/2019 | Braintree Laboratories, Inc. | MOTOFEN (Drug), SUPREP BOWEL PREP | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: GASTROENTEROLOGY - DIARRHEA | ||||||
| 04/01/2019 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $121.26 | General |
| Category: Immunology | ||||||
| 03/28/2019 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $93.49 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/12/2019 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 03/07/2019 | Janssen Biotech, Inc. | STELARA (Biological), SIMPONI | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Immunology | ||||||
| 03/06/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/05/2019 | Braintree Laboratories, Inc. | SUPREP BOWEL PREP (Drug), MOTOFEN | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: GI COLON PREP | ||||||
| 02/28/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Virology | ||||||
| 02/26/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Immunology | ||||||
| 02/11/2019 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/04/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/31/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Immunology | ||||||
| 01/29/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Virology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 297 | 341 | $99,612 | $23,476 |
| 2022 | 5 | 263 | 305 | $98,484 | $21,605 |
| 2021 | 8 | 185 | 203 | $57,860 | $15,359 |
| 2020 | 5 | 104 | 139 | $31,038 | $9,007 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 91 | 130 | $32,166 | $8,238 | 25.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 113 | 115 | $32,889 | $7,518 | 22.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 29 | 29 | $13,786 | $2,615 | 19.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $8,022 | $2,329 | 29.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $8,593 | $1,649 | 19.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 25 | 28 | $4,156 | $1,126 | 27.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 83 | 83 | $41,000 | $8,722 | 21.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 67 | 103 | $24,878 | $5,766 | 23.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 45 | 45 | $13,133 | $3,583 | 27.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $11,728 | $1,884 | 16.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 49 | 55 | $7,745 | $1,650 | 21.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 37 | 37 | $13,917 | $4,029 | 29.0% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 37 | 37 | $10,027 | $2,993 | 29.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 32 | 49 | $10,672 | $2,870 | 26.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 20 | $2,240 | $1,397 | 62.4% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 14 | 14 | $8,848 | $1,294 | 14.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 12 | $1,980 | $1,192 | 60.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 11 | 11 | $7,923 | $896.60 | 11.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 22 | 23 | $2,253 | $687.27 | 30.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 35 | 69 | $10,376 | $3,937 | 37.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 20 | 20 | $5,610 | $2,167 | 38.6% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 16 | 16 | $11,550 | $1,446 | 12.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 16 | $1,792 | $904.81 | 50.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 17 | 18 | $1,710 | $552.10 | 32.3% |
About Dr. Michael Blum, M.D
Dr. Michael Blum, M.D is a Gastroenterology healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1134115165.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Blum, M.D has received a total of $4,699 in payments from pharmaceutical and medical device companies, with $100.40 received in 2024. These payments were reported across 227 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,349).
As a Medicare-enrolled provider, Blum has provided services to 849 Medicare beneficiaries, totaling 988 services with total Medicare billing of $69,448. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Fort Wayne, IN
- Active Since 09/26/2005
- Last Updated 12/15/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1134115165
Products in Payments
- Entyvio (Biological) $439.61
- Humira (Biological) $290.30
- Viekira (Drug) $278.60
- Mavyret (Drug) $269.69
- Sucraid (Drug) $255.84
- ELEVIEW (Device) $217.23
- XIFAXAN (Drug) $163.19
- VIBERZI (Drug) $160.40
- GATTEX (Drug) $159.24
- STELARA (Biological) $136.11
- XIFAXANIBSD (Drug) $135.00
- Creon (Drug) $127.14
- ZEPATIER (Drug) $120.27
- LINZESS (Drug) $119.50
- CLENPIQ (Drug) $112.20
- INJECTAFER (Drug) $104.24
- APRISO (Drug) $103.70
- Trulance (Drug) $102.80
- ENTYVIO (Biological) $93.49
- Beacon (Device) $92.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Wayne
Dr. Efesomwan Aisien, M.d, M.D
Gastroenterology — Payments: $89,557
Dr. Abdo Saad, Md, MD
Gastroenterology — Payments: $59,492
Melissa Garrett, Md, MD
Gastroenterology — Payments: $59,090
Dr. Mariajose Rojas De Leon, Md, MD
Gastroenterology — Payments: $39,782
Dr. Kirsten Weiser, M.d, M.D
Gastroenterology — Payments: $20,935
Dr. David Gutman, Md, Facg, MD, FACG
Gastroenterology — Payments: $13,732